Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares: 2012-2025

Historic Treasury Shares for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Sep 2025 value amounting to $408,000.

  • Enanta Pharmaceuticals' Treasury Shares fell 4.67% to $408,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $408,000, marking a year-over-year decrease of 4.67%. This contributed to the annual value of $408,000 for FY2025, which is 4.67% down from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Treasury Shares stood at $2,000 for Q2 2015, which was down 0.00% from $2,000 recorded in Q1 2015.
  • Enanta Pharmaceuticals' 5-year Treasury Shares high stood at $455,000 for Q4 2023, and its period low was $117,000 during Q3 2021.
  • Moreover, its 3-year median value for Treasury Shares was $2,000 (2015), whereas its average is $2,000.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Treasury Shares soared by 165.22% in 2021 and then fell by 5.05% in 2025.
  • Quarterly analysis of 4 years shows Enanta Pharmaceuticals' Treasury Shares stood at $2,000 in 2012, then remained steady at $2,000 in 2013, then remained steady at $2,000 in 2014, then remained steady at $2,000 in 2015.
  • Its last three reported values are $408,000 in Q3 2025, $414,000 for Q2 2025, and $427,000 during Q1 2025.